3 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow Peripheral T-cell Lymphoma: new trials by email Literature Review of Peripheral T-cell Lymphoma trials Research Report on Peripheral T-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma SHR2554/CHOP, SHR2554/CHOEP - Peripheral T-cell Lymphoma | Phase 1 / Phase 2 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 100 | 2023-12-22 | 2024-05-14 |
| CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma Lposomal mitoxantrone hydrochloride,Cyclophosphamide,Vincristine,Etoposide and Prednisone(CMOEP) - Peripheral T-cell Lymphoma | Phase 1 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 18 | 2022-07-07 | 2022-07-14 |
| Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL liposomal mitoxantrone hydrochloride, gemcitabine, dexamethasone, and cisplatin - Treatment, Peripheral T-cell Lymphoma | Phase 1 / Phase 2 | Unknown | Peking Union Medical College Hospital | 60 | 2022-05-01 | 2022-07-01 |
Lymphoma, T-Cell, Peripheral (3)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Lymphoma, T-Cell (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3)
Cisplatin (1) · Dexamethasone (1) · Gemcitabine (1) · Prednisone (1)
Jiangsu HengRui Medicine Co., Ltd. (1) · Peking Union Medical College Hospital (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (3)